Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study
The use of 2×2000 mg myoinositol + 2×200 μg folic acid per day is a safe and promising tool in the effective improvement of symptoms and infertility for patients with a polycystic ovary syndrome (PCOS). Using a questionnaire an observational study was performed under German gynecologists to collect...
Saved in:
| Main Authors: | Pedro-Antonio Regidor, Adolf Eduard Schindler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2016/9537632 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women
by: Ali Cenk Ozay, et al.
Published: (2016-01-01) -
Corrigendum to “Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women”
by: Ali Cenk Ozay, et al.
Published: (2018-01-01) -
A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years
by: Saghar Salehpour, et al.
Published: (2016-01-01) -
Systematic analysis of the pharmacology of myoinositol and D-chiroinositola
by: T. E. Bogacheva, et al.
Published: (2024-06-01) -
The effect of liraglutide on metabolic and reproductive outcomes in infertile women with PCOS: A prospective cohort study
by: Rossella Cannarella, et al.
Published: (2025-09-01)